L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine

Virus-like particles (VLPs) derived from human papillomavirus (HPV) L1 capsid proteins were used for HPV quadrivalent recombinant vaccine. The HPV quadrivalent vaccine is administrated in a 3-dose regimen of initial injection followed by subsequent doses at 2 and 6 months to prevent cervical cancer,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Immune Netw
Autors principals: Akuzum, Begum, Kim, Sinae, Nguyen, Tam Thanh, Hong, Jeawoo, Lee, Siyoung, Kim, Eunhye, Kim, Joohee, Choi, Yeook, Jhun, Hyunjhung, Lee, Youngmin, Kim, Hyunwoo, Sohn, Dong Hyun, Kim, Soohyun
Format: Artigo
Idioma:Inglês
Publicat: The Korean Association of Immunologists 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026689/
https://ncbi.nlm.nih.gov/pubmed/29984037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4110/in.2018.18.e19
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars